RxDoctor Payments Data

Jessica Garcia, MD

Family Medicine · West Palm Beach, FLNPI 1689960718

Payments from drug & device makers

$636in general payments, 2019–2025

Across 23 payments — averaging $27.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$151
  • Boston Scientific$144
  • Amgen$121
  • Boehringer Ingelheim$50
  • AbbVie$44
  • Ferring Pharmaceuticals Inc.$38
  • plus $89 from 3 others

What the payments were for

  • Food & beverage$636100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$636 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$115,383
Medicare patients
354
Services billed
1,938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$131,198
JardianceEmpagliflozin70$77,218
MounjaroTirzepatide35$39,365
EliquisApixaban37$37,532
JanuviaSitagliptin Phosphate30$33,681
FarxigaDapagliflozin Propanediol21$29,220
TradjentaLinagliptin15$23,935
Repatha SureclickEvolocumab11$16,035
MyrbetriqMirabegron11$13,053
LinzessLinaclotide12$12,728
Tresiba Flextouch U-200Insulin Degludec16$10,627
Janumet XrSitagliptin Phos/Metformin Hcl14$10,074
Rosuvastatin Calcium500$7,125
SynthroidLevothyroxine Sodium69$5,215
Atorvastatin Calcium508$5,042

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$50$101,15285 claims
AbbVieLinzess, Synthroid$44$17,94381 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in West Palm Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →